Yang Dong

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 7

Top Topics

Peritoneal Dialysis

Positive Airway Pressure

Artificial Intelligence

Prognostic Factors

Top Venues

Clinical and translational medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Yongjie Wang, Xiaolong Ma, Enjie Xu, Zhen Huang, Chen Yang, Kun-Peng Zhu, Yang Dong, Chun-Lin Zhang
Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index. Clinical and translational medicine 14 (2) (2024)
Yongjie Wang, Xiaolong Ma, Enjie Xu, Zhen Huang, Chen Yang, Kun-Peng Zhu, Yang Dong, Chun-Lin Zhang
Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index. Clinical and translational medicine 14 (2) (2024)
Yongjie Wang, Xiaolong Ma, Enjie Xu, Zhen Huang, Chen Yang, Kun-Peng Zhu, Yang Dong, Chun-Lin Zhang
Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index. Clinical and translational medicine 14 (2) (2024)
Yongjie Wang, Xiaolong Ma, Enjie Xu, Zhen Huang, Chen Yang, Kun-Peng Zhu, Yang Dong, Chun-Lin Zhang
Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index. Clinical and translational medicine 14 (2) (2024)
Yan Zhou, Qing-Cheng Yang, Yang Dong, Tong Ji, Bing Zhang, Cheng Yang, Shuier Zheng, Lina Tang, Chenliang Zhou, Guowei Qian, Yujing Huang, Wenxi Yu, Hongtao Li, Yonggang Wang, Aina He, Zan Shen, Weibin Zhang, Yingqi Hua, Hongyu Bai, Jiayi Zhao, Benjamin X Li, Xiangrong Dai, Jianjun Zhang, Hai-Yan Hu, Yang Yao
First-in-maintenance therapy for localized high-grade osteosarcoma: an open-label phase I/II trial of the anti-PD-L1 antibody ZKAB001. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Hanjun Li, Xiuguo Han, Shengbing Yang, Yongjie Wang, Yang Dong, Ting-Ting Tang
FOXP1 drives osteosarcoma development by repressing P21 and RB transcription downstream of P53. Oncogene 40 (15) (2021)
Shang Sang, Zhichang Zhang, Shu Qin, Changwei Li, Yang Dong
MicroRNA-16-5p Inhibits Osteoclastogenesis in Giant Cell Tumor of Bone. BioMed research international 2017 (2017)